CHA News Article

Medication-Assisted Treatment Guidance Available

The Food and Drug Administration has released new guidance instructing providers not to withhold medication-assisted treatment using buprenorphine and methadone from patients taking drugs that suppress the central nervous system, including benzodiazepines. Although combining these drugs increases the risk of serious side effects, the FDA notes that the harms of untreated opioid addiction can outweigh these risks. Providers are advised to take certain precautions, including developing a treatment plan when these medications are combined. In addition, the agency notes it is requiring changes to medication-assisted treatment drug labels to help decrease the risks of combining medications.